Sfoglia per Autore
Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice.
2005-01-01 Lapidus, R; Tentori, L; Graziani, G; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Zhang, J; and the Guilford PARP Project, G
Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I
2005-01-01 Tentori, L; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Forini, O; Xu, W; Zhang, J; Graziani, G
Role of PARP, NF-kB and telomerase in necrosis induced by selective methylation of N3-adenine.
2005-04-01 Tentori, L; Forini, O; Muzi, A; Vergati, M; Gold, B; Graziani, G
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs.
2005-08-01 Tentori, L; Vergati, M; Muzi, A; Levati, L; Ruffini, F; Forini, O; Vernole, P; Lacal, Pm; Graziani, G
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide
2005-12-01 Tentori, L; Leonetti, C; Scarsella, M; Muzi, A; Vergati, M; Forini, O; Lacal, P; Ruffini, F; Gold, B; Li, W; Zhang, J; Graziani, G
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma.
2006-08-01 Tentori, L; Leonetti, C; Scarsella, M; Muzi, A; Mazzon, E; Vergati, M; Forini, O; Lapidus, R; Xu, W; Dorio, As; Zhang, J; Cuzzocrea, S; Graziani, G
Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors
2007-01-01 Muzi, A; Lacal, P; Dorio, As; Ruffini, F; Scarsella, M; Leonetti, C; Xu, W; Zhang, J; Tentori, L; Graziani, G
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis
2007-01-01 Tentori, L; Lacal, P; Muzi, A; Dorio, As; Leonetti, C; Scarsella, M; Ruffini, F; Min, W; Stoppacciaro, A; Colarossi, C; Wang, Z; Zhang, J; Graziani, G
Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.
2007-01-01 Graziani, G; Tentori, L; Muzi, A; Vergati, M; Tringali, G; Pozzoli, G; Navarra, P
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells.
2008-01-01 Dorio, As; Muzi, A; Lacal, P; Ruffini, F; Shah, G; Zhang, J; Tentori, L; Graziani, G
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation.
2008-01-01 Tentori, L; Muzi, A; Dorio, As; Mazzon, E; Lacal, P; Shah, G; Zhang, J; Nocentini, G; Cuzzocrea, S; Graziani, G
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells
2008-01-01 Iacopino, F; Urbano, R; Graziani, G; Muzi, A; Navarra, P; Sica, G
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma
2008-04-01 Tentori, L; Dorio, As; Muzi, A; Lacal, Pm; Ruffini, F; Navarra, P; Graziani, G
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity
2008-06-01 Tentori, L; Muzi, A; Dorio, As; Bultrini, S; Mazzon, E; Lacal, P; Shah, G; Zhang, J; Navarra, P; Nocentini, G; Cuzzocrea, S; Graziani, G
Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells
2009-03-01 Lacal, Pm; Tentori, L; Muzi, A; Ruffini, F; Dorio, As; Xu, W; Arcelli, D; Zhang, J; Graziani, G
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant
2009-11-01 Fiorani, P; Tesauro, C; Mancini, G; Chillemi, G; D'Annessa, I; Graziani, G; Tentori, L; Muzi, A; Desideri, A
Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies
2010-01-01 Tentori, L; Dorio, As; Mazzon, E; Muzi, A; Saua, A; Cuzzocrea, S; Federici, G; Caccuri, Am; Graziani, G
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent.
2010-06-01 Tentori, L; Muzi, A; Dorio, As; Scarsella, M; Leonetti, C; Shah, G; Xu, W; Camaioni, E; Gold, B; Pellicciari, R; Dantzer, F; Zhang, J; Graziani, G
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB
2011-01-01 Levati, L; Ruffini, F; Muzi, A; Umezawa, K; Graziani, G; D'Atri, S; Lacal, P
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells
2011-01-15 D'Onofrio, G; Tramontano, F; Dorio, As; Muzi, A; Maselli, V; Fulgione, D; Graziani, G; Malanga, M; Quesada, P
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2005 | Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. | Lapidus, R; Tentori, L; Graziani, G; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Zhang, J; and the Guilford PARP Project, G | Intervento a convegno | |
1-gen-2005 | Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I | Tentori, L; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Forini, O; Xu, W; Zhang, J; Graziani, G | Intervento a convegno | |
1-apr-2005 | Role of PARP, NF-kB and telomerase in necrosis induced by selective methylation of N3-adenine. | Tentori, L; Forini, O; Muzi, A; Vergati, M; Gold, B; Graziani, G | Intervento a convegno | |
1-ago-2005 | Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. | Tentori, L; Vergati, M; Muzi, A; Levati, L; Ruffini, F; Forini, O; Vernole, P; Lacal, Pm; Graziani, G | Articolo su rivista | |
1-dic-2005 | Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide | Tentori, L; Leonetti, C; Scarsella, M; Muzi, A; Vergati, M; Forini, O; Lacal, P; Ruffini, F; Gold, B; Li, W; Zhang, J; Graziani, G | Articolo su rivista | |
1-ago-2006 | Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. | Tentori, L; Leonetti, C; Scarsella, M; Muzi, A; Mazzon, E; Vergati, M; Forini, O; Lapidus, R; Xu, W; Dorio, As; Zhang, J; Cuzzocrea, S; Graziani, G | Articolo su rivista | |
1-gen-2007 | Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors | Muzi, A; Lacal, P; Dorio, As; Ruffini, F; Scarsella, M; Leonetti, C; Xu, W; Zhang, J; Tentori, L; Graziani, G | Intervento a convegno | |
1-gen-2007 | Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis | Tentori, L; Lacal, P; Muzi, A; Dorio, As; Leonetti, C; Scarsella, M; Ruffini, F; Min, W; Stoppacciaro, A; Colarossi, C; Wang, Z; Zhang, J; Graziani, G | Articolo su rivista | |
1-gen-2007 | Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. | Graziani, G; Tentori, L; Muzi, A; Vergati, M; Tringali, G; Pozzoli, G; Navarra, P | Articolo su rivista | |
1-gen-2008 | Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. | Dorio, As; Muzi, A; Lacal, P; Ruffini, F; Shah, G; Zhang, J; Tentori, L; Graziani, G | Intervento a convegno | |
1-gen-2008 | Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation. | Tentori, L; Muzi, A; Dorio, As; Mazzon, E; Lacal, P; Shah, G; Zhang, J; Nocentini, G; Cuzzocrea, S; Graziani, G | Intervento a convegno | |
1-gen-2008 | Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells | Iacopino, F; Urbano, R; Graziani, G; Muzi, A; Navarra, P; Sica, G | Articolo su rivista | |
1-apr-2008 | The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma | Tentori, L; Dorio, As; Muzi, A; Lacal, Pm; Ruffini, F; Navarra, P; Graziani, G | Articolo su rivista | |
1-giu-2008 | Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity | Tentori, L; Muzi, A; Dorio, As; Bultrini, S; Mazzon, E; Lacal, P; Shah, G; Zhang, J; Navarra, P; Nocentini, G; Cuzzocrea, S; Graziani, G | Articolo su rivista | |
1-mar-2009 | Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells | Lacal, Pm; Tentori, L; Muzi, A; Ruffini, F; Dorio, As; Xu, W; Arcelli, D; Zhang, J; Graziani, G | Articolo su rivista | |
1-nov-2009 | Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant | Fiorani, P; Tesauro, C; Mancini, G; Chillemi, G; D'Annessa, I; Graziani, G; Tentori, L; Muzi, A; Desideri, A | Articolo su rivista | |
1-gen-2010 | Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies | Tentori, L; Dorio, As; Mazzon, E; Muzi, A; Saua, A; Cuzzocrea, S; Federici, G; Caccuri, Am; Graziani, G | Intervento a convegno | |
1-giu-2010 | Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. | Tentori, L; Muzi, A; Dorio, As; Scarsella, M; Leonetti, C; Shah, G; Xu, W; Camaioni, E; Gold, B; Pellicciari, R; Dantzer, F; Zhang, J; Graziani, G | Articolo su rivista | |
1-gen-2011 | Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB | Levati, L; Ruffini, F; Muzi, A; Umezawa, K; Graziani, G; D'Atri, S; Lacal, P | Articolo su rivista | |
15-gen-2011 | Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells | D'Onofrio, G; Tramontano, F; Dorio, As; Muzi, A; Maselli, V; Fulgione, D; Graziani, G; Malanga, M; Quesada, P | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile